clinical guidance
Articles tagged with “clinical guidance”
Low Dose Ketamine Urinary Tract Long-Term Safety
What patients should know about low dose ketamine urinary tract long-term safety, including monitoring, warning signs, and questions to ask your prescriber.
Ketamine Therapy for Older Adults: Safety Considerations
What older adults and families should know about ketamine therapy safety, blood pressure monitoring, drug interactions, and clinical evidence.
PHQ-9 and GAD-7 in Ketamine Dose Adjustment: A Patient Guide
Learn how PHQ-9 and GAD-7 assessments guide ketamine dose adjustments. Patient-focused guide to understanding symptom tracking and dosing decisions.
Ketamine Side Effects & When to Switch: New Clinical Guidance
New clinical guidance urges tracking PHQ-9 scores, monitoring side effects closely, and switching NMDA treatments sooner to reach remission faster.
Rethinking Treatment-Resistant Depression Care in 2026
New clinical perspectives on treatment-resistant depression push for true remission over symptom reduction. Here's what it means for ketamine patients.
How Clinicians Choose TRD Treatments in 2026
New clinical guidance on treatment-resistant depression highlights how patient preference, speed of response, and functional outcomes shape ketamine treatment decisions.
TRD Management: Why Remission Should Be the Goal
New clinical guidance on treatment-resistant depression urges full remission over symptom reduction — here's what it means for low-dose ketamine patients.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.